Sanofi SA
NASDAQ:SNY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sanofi SA
NASDAQ:SNY
|
FR |
|
K
|
Kinross Gold Corp
NYSE:KGC
|
CA |
|
A
|
Apollo Investment Corp
F:55O1
|
US |
|
Red Sky Energy Ltd
ASX:ROG
|
AU |
|
Paul Merchants Ltd
BSE:539113
|
IN |
|
P
|
Proto Labs Inc
SWB:PRZ
|
US |
|
Nyesa Valores Corporacion
MAD:NYE
|
ES |
|
H
|
Heineken Malaysia Bhd
KLSE:HEIM
|
MY |
|
Isetan Mitsukoshi Holdings Ltd
OTC:IMHDF
|
JP |
|
Integrated Ventures Inc
OTC:INTV
|
US |
|
Nine Entertainment Co Holdings Ltd
ASX:NEC
|
AU |
|
Saturn Oil & Gas Inc
XTSX:SOIL
|
CA |
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
CA |
|
Science Applications International Corp
NASDAQ:SAIC
|
US |
|
A
|
Alamos Gold Inc
NYSE:AGI
|
CA |
|
Arizona Lithium Ltd
ASX:AZL
|
AU |
|
C
|
China Resources Beer Holdings Co Ltd
XHAM:CHK
|
HK |
Wall St Price Targets
SNY Price Targets Summary
Sanofi SA
According to Wall Street analysts, the average 1-year price target for SNY is 55.69 USD with a low forecast of 33.63 USD and a high forecast of 68.71 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SNY's stock price target?
Price Target
55.69
USD
According to Wall Street analysts, the average 1-year price target for SNY is 55.69 USD with a low forecast of 33.63 USD and a high forecast of 68.71 USD.
What is the Revenue forecast for Sanofi SA?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 8 years is 2%.
What is the Operating Income forecast for Sanofi SA?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 8 years is 7%.
What is the Net Income forecast for Sanofi SA?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 8 years is 5%.
